Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

Dr. Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

The Rockefeller University | United States

Dr. Sarah F. Leibowitz is a Research Associate Professor at The Rockefeller University in the Laboratory of Behavioral Neurobiology. With a career dedicated to uncovering the neural basis of addiction, she focuses on how the brain regulates consumption of substances like alcohol and nicotine, as well as high-fat and high-sugar foods. Her pioneering work explores the transition from casual intake to substance dependence, linking specific brain mechanisms to addictive behaviors. Dr. Leibowitz’s research also highlights how emotional traits—such as impulsivity and anxiety—influence substance use. In recent years, she has expanded her work to investigate how maternal diet and drug exposure during pregnancy affect the brain development and behavior of offspring. Her studies reveal persistent neural and behavioral changes that may increase vulnerability to addiction later in life. Through her research, she aims to identify early indicators of addiction risk and explore preventive strategies for substance abuse disorders.

Profile

ORCID

Education

Dr. Sarah F. Leibowitz earned her Ph.D. in behavioral neurobiology, establishing her foundation in neuroscience and psychobiology. Although specific details of her academic institutions are not publicly disclosed, her academic trajectory clearly reflects rigorous training in neurobiology, endocrinology, and developmental neuroscience. Her education emphasized the interplay between brain structure, behavior, and environmental stimuli—especially as related to addiction and nutrition. Over the course of her doctoral and postdoctoral work, she developed specialized expertise in rodent models, neurochemical techniques, and behavioral neuroscience. Her educational background has equipped her to contribute significantly to the understanding of the neural mechanisms underlying addiction, impulsivity, and maternal influences on brain development. Dr. Leibowitz’s academic formation has not only shaped her robust research career but also positioned her as a mentor and thought leader in the intersection of behavioral neuroscience, addiction research, and developmental psychobiology.

 Experience

Dr. Sarah Leibowitz brings decades of experience in behavioral neuroscience, serving as a Research Associate Professor at The Rockefeller University. In this role, she leads research exploring how neurochemical circuits in the brain influence the consumption of addictive substances and palatable foods. Her experience spans experimental neurobiology, developmental studies, and translational addiction research, using advanced rodent models to simulate human behavioral patterns. She has worked extensively on characterizing the neural pathways that control emotional traits such as impulsivity and anxiety, which predispose individuals to addiction. In addition, Dr. Leibowitz has pioneered investigations into prenatal programming—studying how maternal substance use affects offspring neurodevelopment and behavior. Her career has been marked by interdisciplinary collaborations, significant grant support, and mentoring emerging scientists. Dr. Leibowitz’s extensive lab-based research experience has positioned her at the forefront of studies on addiction vulnerability, making meaningful contributions to both basic neuroscience and potential clinical applications.

Awards and Honors

While specific awards and honors for Dr. Sarah F. Leibowitz are not publicly detailed, her long-standing appointment at The Rockefeller University—a prestigious research institution—attests to her outstanding contributions in behavioral neurobiology. Recognition in the scientific community is reflected through her published research, influential collaborations, and leadership in addiction-related neuroscience. She is frequently cited in peer-reviewed journals, indicating strong academic impact and recognition from fellow researchers. Her studies addressing prenatal influences on addiction vulnerability have garnered widespread attention in developmental neuroscience and public health sectors. In addition to academic merit, Dr. Leibowitz’s role as a mentor and educator suggests acknowledgment of her commitment to training the next generation of scientists. The significance and longevity of her research position imply that she has received competitive research funding and peer-reviewed grants, further recognizing the value of her work in advancing understanding of substance use disorders.

Research Focus

Dr. Leibowitz’s research focuses on the neurobiological mechanisms underlying addiction, particularly the transition from use to dependence on substances like alcohol, nicotine, and palatable foods. Her laboratory investigates how neurochemical pathways in various brain regions drive compulsive consumption and are influenced by traits such as novelty seeking, impulsivity, and anxiety. A major area of her research explores the developmental origins of addiction: how maternal consumption of drugs or high-fat/high-sugar diets during pregnancy alters brain development and long-term behavior in offspring. These studies reveal that such prenatal exposures can “reprogram” the brain, increasing susceptibility to substance use disorders in adolescence and adulthood. Through rodent models, Dr. Leibowitz aims to identify biomarkers and early-life predictors of addiction risk, as well as investigate potential interventions for prevention. Her multidisciplinary approach integrates behavioral neuroscience, endocrinology, and developmental biology, contributing valuable insights into addiction’s origins, progression, and possible prevention strategies.

Publications

Title: Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment
Year: 2024
Citations: 2

Title: Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis
Year: 2023
Citations: 8

Title: Role of Chemokine Cxcl12a in Mediating the Stimulatory Effects of Ethanol on Embryonic Development of Subpopulations of Hypocretin/Orexin Neurons and Their Projections
Year: 2023
Citations: 10

Title: Embryonic ethanol exposure induces ectopic Hcrt and MCH neurons outside hypothalamus in rats and zebrafish: Role in ethanol‐induced behavioural disturbances
Year: 2022
Citations: 18

Conclusion

Dr. Sarah F. Leibowitz’s work stands at the intersection of neuroscience, behavior, and developmental biology, providing groundbreaking insights into addiction, prenatal brain development, and preventive strategies for substance use disorders, making her a leading figure in behavioral neurobiology and addiction research.

 

Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda 🌊, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth 🧠, renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care 💡; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology 🏥, academia 📚, and public health advocacy 🧬.

Profile

Education 🎓

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine 🎓; he earned a B.A. with High Honors in Music from Bowdoin College 🎵 (1977), pursued advanced coursework at MIT 🏛️, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole 🔬 — blending physiology, neurology, and music to form a truly interdisciplinary academic foundation 📘.

Experience 👨‍🏫

With over three decades in clinical neurology 🧠, Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013–present) 👨‍🏫; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 🏥, held multiple consultant roles across Vermont and New Hampshire 🗺️, and co-directs the Electromyography Lab ⚡, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments 🌟.

Awards & Recognitions 🏅

Dr. Stommel’s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award 🏆 (2011); he is a Fellow of the American Academy of Neurology 🎖️ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology 🧠, complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education 📋💡.

Research Interests 🔬

Dr. Stommel’s research revolves around neurodegenerative diseases, especially ALS 🧬, exploring environmental toxins 🌿, nanotechnology 🧪, and biomarkers 🔍 to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology 🧠, he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues 🌍💡.

Publications

PİNAR ERKEKOGLU | Neurotoxicology | Best Researcher Award

Prof. PİNAR ERKEKOGLU | Neurotoxicology | Best Researcher Award

Prof. Dr. Pınar Erkekoğlu is a distinguished academician and toxicologist at Hacettepe University, serving as Head of the Department of Pharmaceutical Toxicology and Department of Vaccine Technology. She holds a PhD in toxicology (2009) and became a European Registered Toxicologist (ERT) in 2014. She conducted research at Joseph Fourier University, CEA/INAC/LAN, and completed her postdoctoral studies at MIT (2011-2013). With over 200 scientific publications, 10 edited books, and 15 book chapters, her work spans toxicology, neurotoxicology, and vaccinology. Her h-index is 34, with 107 SCI-indexed papers and numerous collaborations.

Profile

Education 🎓

Prof. Erkekoğlu earned her Pharmacy degree from Hacettepe University and a PhD in toxicology (2009). She gained international research experience at Joseph Fourier University and CEA/INAC/LAN during her doctorate. In 2011-2013, she pursued postdoctoral research at MIT, specializing in toxicology and environmental sciences. Recognized for her expertise, she became a European Registered Toxicologist (ERT) in 2014.

Experience 👨‍🏫

Prof. Erkekoğlu has extensive experience in toxicology, environmental sciences, and vaccinology. She is the Head of Pharmaceutical Toxicology and Vaccine Technology at Hacettepe University. She has worked at MIT, Joseph Fourier University, and CEA/INAC/LAN. With 49 research projects, 4 industry consultancies, and 12 collaborations, she has contributed significantly to toxicological sciences.

Awards & Recognitions 🏅

Prof. Erkekoğlu has received numerous awards, including Best Researcher and Women Researcher Awards. She is recognized internationally for her contributions to toxicology, neurotoxicology, and vaccine technology. She has served as an editor for scientific books, peer-reviewed journals, and major toxicology conferences.

Research Interests 🔬

Her research encompasses neurotoxicology, endocrine disruption, environmental toxicology, and vaccinology. She has published 107 SCI-indexed papers and 161 documents in Scopus across pharmacology, medicine, and environmental sciences. Her work explores the toxic effects of chemicals on human health and vaccine development.

Publications 

  • Prepubertal phthalate exposure can cause histopathological alterations, DNA methylation and histone acetylation changes in rat brain

    Toxicology and Industrial Health
    2025-03 | Journal article
    CONTRIBUTORS: Seyda Koc; Ekin Erdogmus; Ozlem Bozdemir; Deniz Ozkan-Vardar; Unzile Yaman; Pınar
    Erkekoglu; Naciye Dilara Zeybek; Belma Kocer-Gumusel
  • The ameliorative potential of metformin against aluminum‐induced neurotoxicity: Insights from in vitro studies

    Journal of Applied Toxicology
    2025-02 | Journal article
    CONTRIBUTORS: Sonia Sanajou; Anil Yirün; Göksun Demirel; Pinar Erkekoğlu; Gönül Şahin; Terken Baydar
  • Unveiling connections: bisphenol A and vitamin D dynamics in breast milk among healthy lactating mothers

    International Journal of Environmental Health Research
    2024-10-10 | Journal article
    CONTRIBUTORS: Esra Cinkilli Aktağ; Sıddika Songül Yalçin; Anıl Yіrün; Aylin Balci Özyurt; Pınar Erkekoğlu
  • Bisphenol derivatives in cord blood and association between thyroid hormones and potential exposure sources

    International Journal of Environmental Health Research
    2024-08-02 | Journal article
    CONTRIBUTORS: Merve Buke Sahin; Murat Cagan; Anıl Yirun; Aylin Balcı Ozyurt; Selinay Basak Erdemli Kose; Irem Iyigun; Melda Celik; Ozgur Ozyuncu; Pınar Erkekoglu; Cavit Isik Yavuz
  • Comparative in silico and in vitro evaluation of possible toxic effects of bisphenol derivatives in HepG2 cells

    Toxicology Research
    2024-07-01 | Journal article
    CONTRIBUTORS: Aylin Balci-Ozyurt; Anıl Yirun; Deniz Arca Cakır; İbrahim Ozcelik; Merve Bacanli; Gizem Ozkemahli; Suna Sabuncuoglu; Nursen Basaran; Pınar Erkekogl

 

Mostapha Brahmi | Toxicology | Best Researcher Award

Dr. Mostapha Brahmi | Toxicology | Best Researcher Award

Biochemistry at University of Relizane, Algeria

Dr. Mostapha Brahmi is a distinguished researcher and educator in biochemistry and toxicology, recognized for his contributions to understanding the biological impacts of xeno-biotics and essential oil characterization. With an impressive academic and professional trajectory, he serves as a mentor to aspiring scientists and as an active contributor to advancing toxicology and biochemistry research. His dedication is evident through his prolific publications, collaborations with international research institutions, and leadership in academic programs. Dr. Brahmi’s work reflects a commitment to addressing global challenges in toxicology and natural product research, making him a notable figure in his field.

Profile

Google Scholar

Education

Dr. Brahmi completed his Doctorate in Biochemistry and Experimental Toxicology in 2020 from the Université Dr Tahar Moulay Saida, Algeria. Prior to this, he earned a Master’s degree in Biochemistry and Cell Physiology in 2015 from the same university and a Higher Studies Diploma in Biochemistry in 2012 from Université d’Oran Es-Senia. His foundational education began with a Bachelor’s degree in Natural and Life Sciences in 2008 from Lycée Abdelmoumen, Saida, Algeria. This progressive educational journey reflects his consistent focus on advancing his expertise in biochemistry and related disciplines.

Professional Experience

Dr. Brahmi is currently an Associate Lecturer at the National Institute of Higher Paramedical Training, Saida, Algeria, where he teaches toxicology, pharmacology, and pharmacy. Since 2022, he has also been serving as a Lecturer at the University of Relizane, Algeria, teaching biochemistry, enzymology, and toxicology. Additionally, he oversees the Master’s program in Applied Biochemistry at the Department of Biological Sciences, demonstrating his leadership and commitment to academic excellence. Dr. Brahmi has also engaged in foreign research internships in Belgium and France, further enriching his professional portfolio.

Research Interests

Dr. Brahmi’s research focuses on the extraction, purification, and characterization of essential oils and their biological activities. He investigates the toxicological impacts of xeno-biotics, including heavy metals, pesticides, and mycotoxins, on neurotoxicity, hepatotoxicity, and nephrotoxicity. His work also explores the therapeutic potential of natural products in mitigating toxicological effects, contributing to advancements in experimental toxicology and pharmacological applications. His research bridges the gap between natural product chemistry and toxicology, making significant contributions to the scientific understanding of bioactive compounds.

Research Skills

Dr. Brahmi excels in various research methodologies, including in vivo and in vitro biological evaluations, essential oil characterization, and toxicological assays. His expertise extends to assessing neurotoxic, hepatotoxic, and nephrotoxic effects of environmental toxins. Additionally, he is skilled in mentoring and supervising postgraduate students, with a record of guiding 10 Master’s students and co-supervising two doctoral candidates. His editorial contributions to scientific journals and his ability to synthesize complex data further highlight his exceptional research skills.

Awards and Honors

Dr. Brahmi has received recognition for his scholarly contributions through invitations to present at conferences and serve on editorial boards of journals such as Advances in Traditional Medicine and Natural Product Research. His 28 publications in international journals, four authored books, and 35 scientific presentations underscore his academic impact. His dedication to fostering scientific understanding has positioned him as a respected figure in the fields of biochemistry and toxicology.

Publications

Preliminary Study of the Pre-Germinative Treatments of Juniperus oxycedrus L. and Pistacia lentiscus L. in the Saida Region (Western Algeria)

  • Authors: SA Aouadj, M Zouidi, A Allam, M Brahmi, M Djebbouri, Y Nasrallah, …
  • Journal: Biodiversity: Research and Conservation
  • Volume: 67, Pages 13–20
  • Citations: 11
  • Publication Year: 2022

Effets Prophylactiques de l’Huile Essentielle de Syzygium aromaticum Chez les Rats Wistar en Développement Coexposés au Plomb et au Manganèse

  • Authors: DEH Adli, K Kahloula, M Slimani, M Brahmi, M Benreguieg
  • Journal: Phytothérapie
  • Citations: 9
  • Publication Year: 2017

The Therapeutic Effect of Cinnamomum cassia Essential Oil Against Hepatotoxicity Induced by Co-Exposure to Lead and Manganese in Developing Wistar Rats

  • Authors: DEH Adli, M Brahmi, K Kahloula, W Arabi, B Bouzouira, M Talatizi, …
  • Journal: Journal of Drug Delivery and Therapeutics
  • Volume: 10 (5), Pages 49–55
  • Citations: 7
  • Publication Year: 2020

Evaluation of the Therapeutic Effects of Mentha spicata Essential Oil at the Liver Level in Developing Wistar Rats Co-Exposed to Lead and Manganese

  • Authors: M Brahmi, DEH Adli, M Slimani, W Arabi, N Taibi, K Kahloula
  • Journal: Carpathian Journal of Food Science & Technology
  • Volume: 11 (2)
  • Citations: 7
  • Publication Year: 2019

The Efficiency of Syzygium aromaticum Essential Oil Against Renal Intoxication by Lead in Rats During Development

  • Authors: DEH Adli, K Hachem, M Benreguieg, M Brahmi, K Kahloula, S Miloud
  • Journal: Bioscience Research
  • Volume: 15 (3), Pages 2126–2133
  • Citations: 7
  • Publication Year: 2018

Prophylactic Effects of Syzygium aromaticum Essential Oil on Developing Wistar Rats Co-Exposed to Lead and Manganese

  • Authors: DEH Adli, K Kahloula, M Slimani, M Brahmi, M Benreguieg
  • Journal: Phytothérapie
  • Pages: 1–7
  • Citations: 6
  • Publication Year: 2017

Conclusion

Dr. Mostapha Brahmi is an accomplished biochemist and toxicologist whose contributions have advanced the understanding of natural products and toxicology. With a solid educational foundation, extensive professional experience, and a keen interest in impactful research, he embodies the qualities of an innovative and committed scientist. His ability to mentor students, produce high-quality research, and collaborate internationally underscores his role as a leader in his field. Dr. Brahmi’s achievements make him a compelling candidate for recognition and awards celebrating excellence in research.